SALINAS, Calif., May 03, 2007 (BUSINESS WIRE) -- Next Pharmaceuticals announced today that Dr. Marilyn Barrett has signed on as a Scientific Advisor with Next Pharmaceuticals where she will provide pharmacognosy expertise for the company's research and development activities. Dr. Barrett is the principal of Pharmacognosy Consulting, a consulting firm that provides scientific information and technical expertise to manufacturers, law offices, associations and government concerning medicinal plant products and nutritional dietary supplements.
Next Pharmaceuticals (NP) was founded with the purpose of developing new, patented, natural ingredients for healthy living products in the dietary supplement, food and beverage industries. The goal of the company is to expand self-care and preventative health maintenance. NP has successfully developed six plant extracts, both patented and proprietary, plus Chromulin(TM), a new form of the essential trace mineral chromium for potentiating insulin. These products have significantly expanded the choices for self-care products while providing consumer brands with powerful product differentiation. Through the application of pharmaceutical technologies to natural botanical materials, including citrus fruits, NP has developed Relora(R) for relaxation and stress-related appetite control, Seditol(R) for better quality of sleep, Nexrutine(R) for inflammation, Citri-Z(R) for heart health; Flavoxine(TM) for healthy cholesterol, and Citrofen(TM) for mobility and comfort.